Company profile: Galenicum
1.1 - Company Overview
Company description
- Provider of pharmaceutical products and services, including R&D, regulatory affairs, manufacturing, licensing, and global supply across technologies from injectables to oral solids and nasal sprays. Operates a facility near Madrid producing over 50 million packs annually, trades APIs, and markets Vitae bioequivalent medicines and Galenicum Derma specialty dermatology products; applies QbD standards in development.
Products and services
- Research and Development: QbD-driven R&D architects finished dosage forms, integrating regulatory affairs and intellectual property management across injectables, oral solids, and nasal sprays to deliver affordable medicines
- Development, Licensing, and Supply: End-to-end operations develop, license, and supply affordable medicines globally, covering the entire industry value chain with technologies spanning injectables, oral solids, and nasal sprays
- Manufacturing: Large-scale facility near Madrid fabricates over 50 million packs annually across formats, including injectables, oral solid forms, and nasal sprays.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Galenicum
Societal CDMO
HQ: United States
Website
- Description: Provider of contract development and manufacturing services focused on small molecule therapies, including drug product formulation development; clinical and commercial manufacturing of solid and liquid products (including controlled substances and high-potency molecules); analytical development and QC testing; clinical trial packaging and labeling; and regulatory consulting and FDA submission support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Societal CDMO company profile →
Bachem
HQ: Switzerland
Website
- Description: Provider of full-service biochemicals to the pharma and biotech industry; an independent, technology-based company specializing in process development and GMP manufacturing of peptide and oligonucleotide APIs, complex organic molecules, and innovative research biochemicals. Offers research-grade and GMP peptides, oligonucleotide NCE development, commercial APIs and generics, catalog peptides, custom peptide synthesis, amino acid derivatives, and products for diagnostics and cosmetics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bachem company profile →
Eximia Research
HQ: United States
Website
- Description: Provider of multi-therapeutic clinical research site network services for biotech companies, conducting Phase I–IV clinical trials across therapeutic and diagnostic indications. Offers patient recruitment and engagement (including underrepresented populations), feasibility studies with investigator feedback, rapid site start-up and feasibility, regulatory and start-up support (contract and budget management), and quality assurance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eximia Research company profile →
Gelpell
HQ: Switzerland
Website
- Description: Provider of manufacturing for food supplements and nutrients, offering soft gelatin capsules for oily and semi-solid preparations; Gelpell® beads for slow, even release and improved bioavailability; hard capsules with powders or Gelpell® beads; plant-based pea-starch soft capsules; blister packaging compliant with pharmaceutical standards; and bulk product supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gelpell company profile →
Dalton Pharma Services
HQ: Canada
Website
- Description: Provider of cGMP contract drug discovery, development, and manufacturing services to pharmaceutical and biotechnology industries. FDA-registered and Health Canada approved with over 30 years of experience. Offerings include cGMP API manufacturing, custom chemical synthesis, formulation development, sterile filling services, accelerated stability testing, and conjugation services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dalton Pharma Services company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Galenicum
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Galenicum
2.2 - Growth funds investing in similar companies to Galenicum
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Galenicum
4.2 - Public trading comparable groups for Galenicum
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →